NOW AVAILABLE on the APP Store and Google Play: The Lesion Area Mapping Assistant (LAMA) is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials. Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs,…
DetailsOn behalf of our CEO Eric Zudak, all of us at Thalocan Research Innovations congratulate everyone at AAD on the success of the 2026 Innovation Academy. So grateful for the conversations, the insights and learning about all of the new breakthroughs in dermatology. We’ll see you again, next year!
Innovation. That’s what we’re about, too. Tomorrow, Thalocan Research Innovations CEO Eric Zudak begins four days at AAD innovation Academy 2026 – packed with the latest breakthroughs in dermatology, cutting-edge clinical insights and meaningful networking moments. Here at TRI we share this mindset of creating and sharing innovative and state-of-the-art technologies to assist physicians, trialists…
DetailsWith the release of several new and updated trainings in the coming weeks, Thalocan Research Innovations continues to establish itself as an industry leader for Investigator Training Content and Resources. Our standard and customized assessment training material is authored by globally recognized disease-specific key opinion leaders and experienced trialists. Our Creative Team enhances the content…
DetailsLooking forward to next week, when Thalocan Research Innovations CEO Eric Zudak heads to 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. And when it comes to cutting edge, TRI is proud to deliver TRICOA, the first…
DetailsThe Story Behind the Science A Conversation with Paul Stroili, Vice President of Creative by Ginger Claremohr, Claremohr Writing Co. A Life in Stories Long before he was helping shape the visual identity of Thalocan Research Innovations, Paul Stroili was telling stories from a stage. For more than four decades, he has worked as an…
DetailsThalocan Research Innovations CEO Eric Zudak is heading to New York City, July 16–19, for The 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. One breakthrough sure to be discussed is the enthusiastic response to our Lesion…
DetailsToday is World Vitiligo Day, a global campaign dedicated to raising awareness, ending social stigma, and advocating for people living with vitiligo. Originally launched in 2011, the day unites the international community to promote research and support for those affected. At Thalocan Research Innovations Research Innovtions, we applaud the work of the GLOBAL VITILIGO FOUNDATION…
DetailsThalocan Research Innovations team members Eric Zudak, Teresa DeHaemer and Tyler White are looking forward to an exciting few days at the Revolutionizing Atopic Dermatitis Conference (RAD 2026) in Nashville. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Our TRI team will…
DetailsSpeaking the Same Language: Continuous Improvement at Every Level A conversation with Maggie Ellis, founder of Fluent Fox Language Solutions and a valued partner in Thalocan’s culture of continuous improvement. by Ginger Claremohr, Claremohr Writing Co. Long Before Brazil When Maggie Ellis traveled to Brazil, she described the experience as something that felt, in her…
Details
